139 results
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
3:28pm
candidates;
third-party payor reimbursement practices;
our ability to adequately protect the intellectual property of our drug candidates;
infringement … candidates;
third-party payor reimbursement practices;
our ability to adequately protect the intellectual property of our drug candidates
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
9:17am
of our drug candidates;
third-party payor reimbursement practices;
our ability to adequately protect the intellectual property of our drug candidates … -party payor reimbursement practices;
our ability to adequately protect the intellectual property of our drug candidates;
infringement
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other employee benefits, including stock option
424B5
z1dt9a
4 Apr 24
Prospectus supplement for primary offering
4:33pm
424B5
sj9r1kb
27 Mar 24
Prospectus supplement for primary offering
8:15am
8-K
EX-10.1
f9apcc 1nu4hdhyip
26 Mar 24
Entry into a Material Definitive Agreement
8:03am